This study is currently recruiting participants.
Number
17-C-0044
Sponsoring Institute
National Cancer Institute (NCI)
Recruitment Detail
Type: Participants currently recruited/enrolled Gender: Male & Female Min Age: 2 Years Max Age: N/A
Referral Letter Required
No
Population Exclusion(s)
None
Keywords
Screening; Heritable Gastric Malignancy; Molecular Profiling; Molecular Alterations
Recruitment Keyword(s)
Condition(s)
Stomach Neoplasms; Stomach Cancer
Investigational Drug(s)
Investigational Device(s)
Intervention(s)
Supporting Site
National Cancer Institute
Certain stomach cancers are rare, but they have high mortality rates. Researchers want to learn more about gastric (stomach) tumors. In this study, they want to collect data from people who have stomach cancer or are at risk to get it. This data will be used to see if the people can be in other studies.
Objective:
To study tissue from stomach tumors and find people eligible for more studies on gastric cancer.
Eligibility:
Age greater than or equal to 2 years old who have or may have stomach cancer, lesions that may be related to stomach cancer, or an inherited disorder that leads to stomach cancer.
Design:
Participants will be screened with:
Medical history
Physical exam
Blood and urine tests
Heart tests
Scans or ultrasound.
For the scans, participants lie in a machine that takes pictures. For some scans, they will swallow or be injected with a small amount of radioactive material. Special cameras will show the material in the body.
Tumor sample taken with a needle or surgery
Some participants will have an endoscopy. A long, flexible tube with a camera will be inserted through the mouth into the stomach. The tube will collect tissue from the stomach.
Some participants may have follow-up visits. Some may be invited to join other studies. Others will be contacted by phone to see how they are doing.
--Back to Top--
INCLUSION CRITERIA: -Patients with the following are eligible: --Malignant or non-invasive, neoplastic lesions of the stomach confirmed by histopathology or cytopathology in a CLIA-certified laboratory OR --Suspicious lesions not yet confirmed, but considered likely to be related to the stomach pending further evaluation OR --Confirmed, deleterious germline mutation (including but not limited to HDGC, GAPPS) known to predispose to gastric tumors; --Confirmed or suspicious heritable gastric malignancy disorder; --Clinically suspicious personal or family medical history of gastric cancer or gastric cancer syndrome that warrants genetics evaluation. -Patients must have an ECOG performance score of 0-2. -Age greater than or equal to 2 years. Note: Patients greater than or equal to 2 and less than or equal to 18 years of age may only participate in research sample collection if the tissue acquisition is performed during a clinically indicated surgical procedure, and the sampling of tissue, blood and urine does not add risk to the clinically indicated procedures. -The patient is a candidate for the clinically indicated medical evaluations that are being offered -Ability of subject, their parents/guardians or legally authorized representative (LAR) to understand and must be willing to sign a written informed consent document. EXCLUSION CRITERIA: Candidates who do not meet the inclusion criteria.
-Patients with the following are eligible:
--Malignant or non-invasive, neoplastic lesions of the stomach confirmed by histopathology or cytopathology in a CLIA-certified laboratory
OR
--Suspicious lesions not yet confirmed, but considered likely to be related to the stomach pending further evaluation
--Confirmed, deleterious germline mutation (including but not limited to HDGC, GAPPS) known to predispose to gastric tumors;
--Confirmed or suspicious heritable gastric malignancy disorder;
--Clinically suspicious personal or family medical history of gastric cancer or gastric cancer syndrome that warrants genetics evaluation.
-Patients must have an ECOG performance score of 0-2.
-Age greater than or equal to 2 years. Note: Patients greater than or equal to 2 and less than or equal to 18 years of age may only participate in research sample collection if the tissue acquisition is performed during a clinically indicated surgical procedure, and the sampling of tissue, blood and urine does not add risk to the clinically indicated procedures.
-The patient is a candidate for the clinically indicated medical evaluations that are being offered
-Ability of subject, their parents/guardians or legally authorized representative (LAR) to understand and must be willing to sign a written informed consent document.
EXCLUSION CRITERIA:
Candidates who do not meet the inclusion criteria.
Principal Investigator
Referral Contact
For more information: